ESTRO35 Programme Book

17:20 > The PROS-IT CNR study: comorbidities and medications at the time of diagnosis of prostate cancer S. Magrini (Italy), U. Ricardi, F. Bertoni, R. Corvò, E. Russi, R. Santoni, W. Artibani, P. Bassi, S. Bracarda, G. Conti, M. Gacci, P. Graziotti, S. Maggi, V. Mirone, R. Montironi, G. Muto, S. Pecoraro, A. Porreca, A. Tubaro, V. Zagonel, F. Zattoni, G. Crepaldi

SATURDAY 30 APRIL 2016

OC-0146

Proffered Papers BRACHYTHERAPY 2: EYE GI 16:30 - 17:30 | ROOM 4 Chair: J. Hannoun-Levi (France) Chair: L. Tagliaferri (Italy)

16:30 > Organ preservation in T2 T3 NX M0 rectal. French results using the new Papillon 50TM machine J.P. Gérard (France), A. Frin, J. Doyen, N. Barbet, R. Coquard, K. Benezery, S. Marcié 16:40 > Evaluation of EBRT and HDRBT for inoperable rectal cancer patients: an update of the HERBERT study

OC-0147

E.C. Rijkmans (The Netherlands), L.A. Velema, A. Cats, K.J. Neelis, Y.M. Van der Linden, R.A. Nout, B. Van Triest, J. Buijsen, T. Rozema, M. Ketelaars, C.A.M. Marijnen

OC-0148

16:50 > Patterns of relapse in rectal cancer patients following pre-operative high dose rate brachytherapy T. Vuong (Canada), F. Desjardins, V. Pelsser, T. Niazi, A. Robillard, M. Leventhal 17:00 > Intraluminal brachytherapy in unresectable biliary carcinoma with malignant biliary obstruction N. Rastogi (India), V.A. Saraswat, S.S. Baijal 17:10 > Radiation induced toxicity and tumour control in pts treated for uveal melanoma with ru-106 plaques C.A. Espensen (Denmark), L.S. Fog, M.C. Aznar, L. Specht, J.F. Kiilgaard 17:20 > Novel software modules for treatment planning of 106Ru eye plaque brachytherapy G. Heilemann (Austria), L. Fetty, I. Birlescu, M. Blaickner, N. Nesvacil, D. Georg

OC-0149

OC-0150

OC-0151

OC-0152

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

82